Dickey’s Barbecue Pit Announces International Expansion into the Philippines

World’s largest barbecue concept opening stores in Manila, Philippines

Dallas, Jan. 23, 2023 (GLOBE NEWSWIRE) — Dickey’s Barbecue Pit is continuing its smoking-hot development streak across the globe as the iconic Texas-born brand announced their expansion into the Philippines.

With this exciting global expansion news, Dickey’s Executive Vice President Jim Perkins and Master Partner, John Lee, of the San Francisco Bay area recently visited the Philippines with a solid foundation in place to open the first Dickey’s Barbecue Pit in Manila in the second Quarter of 2023.

John Lee is a real estate professional, as well as a restaurateur who already own a Dickey’s Barbecue Pit in the San Francisco Bay Area, a national burger chain, as well as having created his own concepts, including Burmese and Peruvian eateries. John’s son, Max Lee, current Owner/Operator of the Bay Area Dickey’s, will lead the expansion in the Philippines and the development of an additional 40 locations.

“We are absolutely thrilled to be bringing the best Legit. Texas. Barbecue. across the globe to the Philippines in 2023,” said Jim Perkins. “With the representation of the Lee family, we have no doubt that the upcoming Dickey’s development will be a major success.”

With this latest announcement, Dickey’s continues to strengthen its international presence as the world’s largest barbecue brand and franchise. With over 550 barbecue restaurants including in Brazil, Egypt, Japan, Pakistan, Singapore, and the United Arab Emirates.

To learn more, follow Dickey’s Barbecue Pit on FacebookInstagram and Twitter. Download the Dickey’s Barbecue Pit app from the Apple App Store or Google Play.

To learn more about Dickey’s Virtual Concepts follow: Wing Boss on FacebookInstagram and Tik TokTrailer Birds on FacebookInstagram and Tik Tok and Big Deal Burger on FacebookInstagram and Tik Tok

About Dickey’s Barbecue Restaurants, Inc.

Dickey’s Barbecue Restaurants, Inc., the world’s largest barbecue concept, was founded in 1941 by the Dickey family. For the past 80 years, Dickey’s Barbecue Pit has served millions of guests in 44 states Legit. Texas. Barbecue.™ At Dickey’s, all our barbecued meats are smoked onsite in a hickory wood burning pit. Dickey’s proudly believes there’s no shortcut to true barbecue and it’s why our name isn’t BBQ. The Dallas-based, family-run barbecue franchise offers eight slow-smoked meats and 12 wholesome sides with ‘No B.S. (Bad Stuff)’ included. Dickey’s Barbecue has 550 locations across the United States and eight other countries.

Dickey’s was named to Newsweek’s 2022 America’s Favorite Restaurant Chains list and USA Today 2021 readers’ choice awards. Dickey’s won first place on Fast Casual’s “Top 100 Movers and Shakers” list, been named a Top 500 Franchise by Entrepreneur and named to Hospitality Technology’s Industry Heroes list. Led by CEO Laura Rea Dickey, who was named among the country’s 50 most influential women in foodservice in Nation’s Restaurant News, was recognized by Fast Casual’s Top 100 Movers and Shakers list and honored by Dallas Business Journal. Dickey’s Barbecue Pit has also been recognized by Fox News, Forbes Magazine, Franchise Times, The Dallas Morning News, The Wall Street Journal, People Magazine and QSR Magazine. Dickey’s Barbecue is part of Dickey’s Restaurant Brands which has more than 700 restaurants nationwide including brands Wing Boss, Trailer Birds, Big Deal Burger and bbqathome.com. DRB is led by CEO Roland Dickey Jr. For more information, visit www.dickeys.com.


Shannon Santos
Dickey's Barbecue Pit

GlobeNewswire Distribution ID 8734747

McKinsey & Company Acquires Iguazio to Accelerate & Scale Enterprise AI

Acquisition will enable Artificial Intelligence’s (AI) full power and potential to be realized across commercial, social, and environmental initiatives.

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) — McKinsey & Company today (23rd January) announced that it has acquired Iguazio, a Tel-Aviv-based leader in Artificial Intelligence and Machine Learning. McKinsey will be able to accelerate and scale AI deployments dramatically with the addition of Iguazio’s technology and a team of 70+ data and AI experts.

To thrive in today’s competitive market, harnessing the power of Artificial Intelligence (AI) is essential. According to McKinsey research, more than $490B was invested in AI by organizations around the globe from 2012-2021. But for most, the actual value of those investments has yet to be realized, with only one in ten projects making it outside the lab.

QuantumBlack, AI by McKinsey has been working with clients to address these challenges head-on and embed AI into real time decision-making. The final element we have been working on is a technology solution that will accelerate AI deployment, embedding it in real-time and in any environment.

“After analysing more than 1000 AI companies worldwide, Iguazio was identified as the best fit to help us significantly accelerate our AI offering – from the initial concept to production, in a simplified, scalable and automated manner,” said Ben Ellencweig, McKinsey senior partner and QuantumBlack global leader of alliances and acquisitions. “By joining forces with Iguazio, we can now deepen the unparalleled, disruptive, end-to-end AI capabilities we offer to our clients.”

Working with Iguazio, QuantumBlack will now be able to provide clients with industry-specific AI solutions that are five times more productive, eight times faster from proof-of-concept to production and twice as reliable.

“McKinsey’s experience and QuantumBlack’s technology stack and expertise, now coupled with Iguazio, is the ultimate solution for enterprises looking to scale AI initiatives in a way that directly impacts their bottom line,” said Asaf Somekh, co-founder and CEO of Iguazio. “We’re thrilled to join the McKinsey family and embark on this next chapter for Iguazio.”

“We are committed to unlocking the full potential of AI to help clients drive sustainable, inclusive growth. Today, as 90 percent of AI projects remain in the lab, there is a big opportunity,” said Alexander Sukharevsky, senior partner and global co-leader of QuantumBlack. “By combining Iguazio and QuantumBlack, we have now deepened the end-to-end offering that will allow us to embed AI in every important step of decision making in real time.”

Alex Singla, senior partner, and global co-leader of QuantumBlack, added, “By combining our people, technology, data assets and domain expertise, we are able to dramatically speed up, scale and productionize AI implementations, staying at the cutting edge of technology while maintaining reliability and scalability.”

This is McKinsey’s first acquisition in Israel. As part of our commitment to serve clients globally, Iguazio will serve as the foundation for a new QuantumBlack location, which McKinsey plans to grow and expand in the coming years.

About McKinsey & Company
McKinsey & Company is a global management consulting firm committed to helping organizations realize sustainable, inclusive growth. We work with clients across the private, public, and social sectors to solve complex problems and create positive change for all our stakeholders. We combine bold strategies and transformative technologies to help organizations innovate more sustainably, achieve lasting gains in performance, and build workforces that will thrive for in this generation and the next.

QuantumBlack, AI by McKinsey, is McKinsey’s AI arm and helps companies transform using the power of technology, technical expertise, and industry experts. With thousands of practitioners at QuantumBlack (Data Engineers, Data Scientists, Product Managers, Designers, Software Engineers) and McKinsey (Industry and Domain experts), we are working to solve the world’s most important AI challenges. QuantumBlack Labs is our center of technology development and client innovation which has been driving cutting-edge advancements and developments in AI through locations across the globe.

Press contact: katherine_shenton@mckinsey.com & media_relations@mckinsey.com

About Iguazio
The Iguazio MLOps Platform enables enterprises to develop, deploy and manage AI applications in an efficient, scalable and repeatable way. Using Iguazio, enterprises can generate business value faster with AI, by accelerating the path to production and continuously rolling out new AI services in a fraction of the time and resources. Enterprises spanning a wide range of verticals, including financial services, healthcare, manufacturing, smart mobility, telecoms and entertainment use Iguazio to turn data science into business impact. Iguazio is backed by prominent investors including Pitango, JVP, Magma VC, INcapital Ventures, Kensington Capital Partners, Verizon Ventures, CME Group, Bosch, Samsung and Dell. Iguazio brings data science to life. Find out more on www.iguazio.com.

Press Contact Sahar Dolev-Blitental – press@iguazio.com

GlobeNewswire Distribution ID 8734730

รายงานแนวปฏิบัติด้านการกำกับดูแลความยั่งยืนของธนาคารขนาดใหญ่ที่สุด 30 แห่งทั่วโลกมาพร้อมกับผลการศึกษาที่น่าสนใจ

ลอนดอน, Jan. 23, 2023 (GLOBE NEWSWIRE) — Morrow Sodali และ Nestor Advisors – ซึ่งเป็นบริษัทของ Morrow Sodali มีความยินดีที่จะประกาศการเผยแพร่ “Governance of sustainability in the largest global banks: “A study of the top 30 European and North American banks.” (การกำกับดูแลความยั่งยืนในธนาคารระดับโลกที่ใหญ่ที่สุด: การศึกษาธนาคารชั้นนำ 30 แห่งในยุโรปและอเมริกาเหนือ)

รายงานนี้ได้แสดงถึงแนวปฏิบัติด้านการกำกับดูแลความยั่งยืนของธนาคารที่ใหญ่ที่สุดในยุโรปและอเมริกาเหนือ 30 แห่ง ในการจัดทำรายงาน เราได้ตรวจสอบเอกสารต่าง ๆ ที่เปิดเผยต่อสาธารณะ และสัมภาษณ์ตัวแทนจากธนาคารชั้นนำ 15 แห่ง รวมทั้งประธานคณะกรรมการ 9 คน สมาชิกคณะกรรมการคนอื่น ๆ และผู้บริหารระดับสูง ผู้ให้สัมภาษณ์ให้ความกระจ่างเกี่ยวกับแนวทางปฏิบัติต่าง ๆ และเหตุใดธนาคารจึงเลือกที่จะดำเนินการดังกล่าว รายงานที่นำเสนอผลลัพธ์นั้นจะเปรียบเทียบธนาคารในจุดข้อมูลต่าง ๆ และวิเคราะห์สิ่งที่ค้นพบเหล่านี้เทียบกับดัชนีความยั่งยืนและประสิทธิภาพทางการเงินในสองแง่

Stilpon Nestor ผู้เขียนหลักของรายงานกล่าวว่า “ความยั่งยืนเป็นหนึ่งในประเด็นใหญ่ที่ธนาคารและผู้นำต้องเผชิญ ผู้ถือหุ้นและผู้มีส่วนได้ส่วนเสียต่าง ๆ รวมทั้งหน่วยงานกำกับดูแลนั้นต่างก็คาดหวังว่าธนาคารจะดำเนินการเชิงรุกในด้านความยั่งยืน ในด้านกลยุทธ์ “การทำให้หนังสือเป็นสีเขียว” ถือเป็นความท้าทายครั้งใหญ่ โดยเฉพาะอย่างยิ่งในตลาดที่มีภาคส่วน “สีน้ำตาล” ขนาดใหญ่ ในด้านความเสี่ยง หน่วยงานกำกับดูแลบางแห่งคาดหวังให้ธนาคารรวมความเสี่ยงด้านความยั่งยืนไว้ในกรอบการบริหารความเสี่ยงหลักและหมวดหมู่หลัก อีกทั้งพวกเขาก็ยังคาดหวังมุมมองด้านความยั่งยืนที่ชัดเจนในกรอบความเสี่ยงที่ยอมรับได้ เพื่อส่งมอบความสามารถในด้านเหล่านี้ ธนาคารทั่วโลกจึงได้เปลี่ยนโฉมหน้าการกำกับดูแลและการจัดการองค์กรที่มีอยู่และได้พัฒนาสิ่งใหม่ ๆ รายงานของเราตรวจสอบข้อตกลงเหล่านี้และเสนอข้อค้นพบต่าง ๆ ที่น่าสนใจ ซึ่งบางครั้งการค้นพบนั้นก็ขัดกับความรู้สึก”

ท่ามกลางข้อค้นพบเหล่านี้ ได้มีการเน้นประเด็นทักษะของคณะกรรมการที่เกี่ยวข้องกับความยั่งยืนด้วย ธนาคารทุกแห่งที่เราได้สัมภาษณ์ไปนั้นไม่เห็นว่าการมีผู้เชี่ยวชาญด้านความยั่งยืนอยู่ในรายชื่อคณะกรรมการเป็นเรื่องสำคัญอันดับต้น ๆ สิ่งสำคัญอันดับแรกของธนาคารคือการทำให้สมาชิกคณะกรรมการที่มีอยู่มีความรู้ความเข้าใจในด้านความยั่งยืนมากขึ้น ในแง่นั้น จึงทำให้พวกเขาเน้นไปที่การพัฒนาทักษะของผู้อำนวยการบริษัท

ส่วนเรื่องที่ว่าการจัดโครงสร้างคณะกรรมการเพื่อจัดการกับความยั่งยืนทำอย่างไรนั้น ในหลาย ๆ กรณีสามารถทำได้โดยการตั้งคณะกรรมการชุดใหม่ อย่างไรก็ตาม โครงสร้างมักจะสะท้อนถึงระดับความสุกงอมของปัญหาในธนาคาร การค้นพบที่น่าสนใจประการหนึ่งของรายงานคือธนาคารที่ก้าวล้ำไปอีกขั้นใน “ขอบเขตที่เติบโตอย่างเต็มที่” นั้น ได้ดำเนิการโดยใช้คณะกรรมการพิเศษและหารือเกี่ยวกับความยั่งยืนให้เป็นส่วนหนึ่งของกลยุทธ์ทั่วไปและความเสี่ยงที่ยอมรับได้

การค้นพบที่สำคัญอีกประการหนึ่งเกี่ยวข้องกับบทบาทของฝ่ายบริหาร ในการทำให้มั่นใจว่าฟังก์ชันทางธุรกิจทั้งหมดจะเสริมสร้างขีดความสามารถในการทำความเข้าใจเกี่ยวกับความยั่งยืนได้ นี่เป็นประเด็นที่กระทบกับทุกส่วนธุรกิจของธนาคาร ไม่ว่าจะเป็นธนาคารที่เป็นองค์กร ธนาคารรายย่อย หรือธนาคารเอกชน ตลอดจนความเสี่ยง การเงิน และการตรวจสอบภายใน นั่นคือเหตุผลที่ธนาคารทั่วโลกส่วนใหญ่จัดตั้งคณะกรรมการบริหารระดับสูงเพื่อดูแลงานข้ามสายงานนี้ ความอาวุโสของสมาชิกของคณะกรรมการนี้เป็นสิ่งสำคัญ ในธนาคารต่าง ๆ 50% ประธานเจ้าหน้าที่บริหารเองก็รับหน้าที่เป็นหัวหน้าคณะกรรมการประสานงานอาวุโสนี้

ธนาคารส่วนใหญ่ได้รวมพารามิเตอร์ความยั่งยืนไว้ในแนวทางการจ่ายค่าตอบแทนผู้บริหารด้วย จากรายงานพบว่าในธนาคารที่มีการดำเนินการที่ดีที่สุด การพิจารณาเรื่องความยั่งยืนนั้นมี “น้ำหนัก” ที่ค่อนข้างมีผลสำคัญท่ามกลางปัจจัยอื่น ๆ ในการพิจารณาค่าตอบแทนที่ผันแปร

เราหวังว่าคุณจะพบว่าการศึกษานี้มีประโยชน์อย่างลึกซึ้ง และการค้นพบนี้จะเป็นประโยชน์จากมุมมองของผู้มีส่วนได้ส่วนเสียทั้งหมด คลิกที่นี่ เพื่อขอรายงานฉบับเต็ม


Morrow Sodali เป็นผู้ให้บริการชั้นนำด้านคำแนะนำเชิงกลยุทธ์และบริการเกี่ยวกับความต้องการของผู้ถือหุ้นแก่ลูกค้าที่เป็นองค์กรทั่วโลก บริษัทให้คำแนะนำเชิงกลยุทธ์แก่คณะกรรมการบริษัทและผู้บริหาร และบริการที่เกี่ยวข้องกับการกำกับดูแลกิจการ แนวคิดเกี่ยวกับการพัฒนาขององค์กรอย่างยั่งยืน (ESG) การสื่อสารและการมีส่วนร่วมของผู้ถือหุ้นและผู้ถือหุ้นกู้ ข่าวกรองตลาดทุน การชักชวนตัวแทน การเคลื่อนไหวของผู้ถือหุ้น และการควบรวมกิจการ

Morrow Sodali ให้บริการลูกค้าที่เป็นองค์กรกว่า 1,000 รายใน 80 ประเทศ ตั้งแต่สำนักงานใหญ่ในนิวยอร์กและลอนดอน ไปจนถึงสำนักงานและพันธมิตรในตลาดทุนหลัก รวมทั้งบริษัทข้ามชาติที่ใหญ่ที่สุดในโลกหลายแห่ง นอกจากบริษัทจดทะเบียนและบริษัทเอกชนแล้ว ลูกค้าของบริษัทยังรวมถึงสถาบันการเงิน กองทุนรวม กองทุนรวมดัชนี (ETF) ตลาดหลักทรัพย์ และสมาคมสมาชิก

สำหรับข้อมูลเพิ่มเติม กรุณาเยี่ยมชม morrowsodali.com


Nestor Advisors เป็นคณะกรรมการเฉพาะด้านและที่ปรึกษาด้านการกำกับดูแลของ Morrow Sodali เราเป็นบริษัทที่ปรึกษาระดับโลกที่เชี่ยวชาญด้านบรรษัทภิบาล ความยั่งยืน และการออกแบบองค์กร และได้ทำงานร่วมกับคณะกรรมการและผู้บริหารระดับสูงของสถาบันการเงิน บริษัท และองค์กรที่ไม่แสวงหาผลกำไรเพื่อปรับปรุงการตัดสินใจ โครงสร้างองค์กร การควบคุม และสิ่งจูงใจ

เมื่อรวมเข้ากับ Morrow Sodali อย่างสมบูรณ์แล้ว บริษัททั้งสองจะมอบชุดบริการที่ปรึกษาที่ครอบคลุมเกี่ยวกับการกำกับดูแลกิจการ แนวคิดเกี่ยวกับการพัฒนาขององค์กรอย่างยั่งยืน (ESG) ความยั่งยืน และการมีส่วนร่วมของผู้มีส่วนได้ส่วนเสียให้แก่ฐานลูกค้าทั่วโลกของบริษัท

บริการของเรามีขอบเขตการให้บริการในวงกว้าง ซึ่งรวมถึงการประเมินแบบองค์รวมซึ่งส่งผลให้มีการออกแบบใหม่ที่สำคัญของระบบการกำกับดูแลของบริษัท การประเมินคณะกรรมการ การกำกับดูแลกลุ่ม การฝึกอบรมคณะกรรมการ การบริหารความเสี่ยง และการพัฒนานโยบายและการควบคุมเฉพาะ บริการของเราจะปรับให้เหมาะกับความต้องการของลูกค้าเสมอ ไม่ว่าขอบเขตความต้องการจะเป็นแบบไหนก็ตาม

สำหรับข้อมูลเพิ่มเติม กรุณาเยี่ยมชม nestoradvisors.com


Elena Cargnello
ผู้อำนวยการ ฝ่ายการตลาด
+44 (0)20 4513 6913

GlobeNewswire Distribution ID 8734712

Acronis Cyber Foundation celebrates five years of giving back to underserved children and communities

Acronis Cyber Foundation Program

Giving back to underserved children and communities

Supporting a range of philanthropic initiatives, the Acronis Cyber Foundation Program, together with our partners, continues to bring educational opportunities and humanitarian efforts to under-resourced areas

SCHAFFHAUSEN, Switzerland, Jan. 23, 2023 (GLOBE NEWSWIRE) — Today, Acronis is proud to celebrate the fifth anniversary of the Acronis Cyber Foundation Program, a set of philanthropic initiatives designed to engage with partners on community development projects and provide volunteering opportunities to team members around the world. Marking five years of monumental success and continuous growth in improving education accessibility, the Program’s key focus is aimed at making education readily available to all and has evolved to include humanitarian disaster relief efforts and environmental projects.

Founded in 2018, the Program has been strongly dedicated to education by funding school construction and bringing IT skills training to communities around the globe. The Acronis Cyber Foundation Program, with collaboration from partners, has built 18 schools with five additional schools in construction progress in 22 different countries. This initiative has benefited over 5,500 students who now have access to quality education. To further support education, 12 schools have been equipped with computer classrooms to provide students with access to technology and the chance to benefit from learning in a digital environment.

In addition to building schools, the Program has engaged in educational projects with over 14,000 people taking part in Acronis IT Skills Training programs and has brought humanitarian aid to over 5,000 individuals in underserved communities. The Program also directly affects the volunteers involved, providing rare exposure to distant parts of the world and the unique experiences each culture offers with 92% of Acronis Cyber Foundation Program volunteers continuing their humanitarian efforts on a yearly basis.

“I am proud of what we achieved through the Acronis Cyber Foundation Program,” said Patrick Pulvermueller, CEO, Acronis. “The Schools Initiative and IT Skills Training program provided much-needed support to those in need, opening a world of new educational and career opportunities. The success of the Acronis Cyber Foundation could not have been reached without the help of our partners. I’d like to thank them for their ongoing support and I have no doubt that our joint efforts will help contribute to a more positive and prosperous future.”

Education has a solid and positive impact on people’s lives, paving the way for future careers in technology, a flourishing global industry. The Acronis Cyber Foundation’s IT training program in Singapore helped over 120 students complete certification training and gain valuable skills to secure employment, in partnership with Yellow Ribbon Fund. The Program recorded that over 70% of IT Skills Training graduates received employment within just one month following course completion. The IT Skills for migrants in Switzerland program, in partnership with Integres, an organization aimed at integrating immigrants into Switzerland, helped the migrant population of Schaffhausen refine and gain critical career skills, helping over 70 students in the span of three years.

“The Acronis Cyber Foundation represents the same values that encouraged me to build the school in a village in the Dominican Republic,” said Sebastian Noelting, Managing Director at RNT Rausch. “We are convinced that problems such as poverty and hunger can only be solved sustainably through education. That is why education must be available to everyone all over the world. I’m glad that we have been able to partner with Acronis and are now working together towards this goal.”

The success of the Acronis Cyber Foundation has been achieved thanks to the help of Acronis’ service provider partners, including GoDaddyCloudFestRNT RauschZebra SystemsClimb Channel SolutionsBusyMouseUbistor, and many more. The Acronis Cyber Foundation Program’s official charity partner, Groundbreaker, ensures compliance and handles all construction aspects in the implementation process for school building projects.

“Acronis has been an important partner for us since the beginning and we are grateful for their commitment to providing access to quality education worldwide,” said Leoni Rossberg, Co-Founder and Managing Director at Groundbreaker. “They show how relevant and impactful corporate responsibility is and we hope they can encourage even more companies in the tech sector to do the same.”

The Acronis Cyber Foundation Program is focused on partnering with other organizations to make a difference together. Acronis invites all businesses, large or small, to engage in joint projects. For partners wanting to develop their own community development plans, the Program can help in supporting other initiatives as well. To join our mission or to learn more, please visit: www.acronis.org.

To discover more about the Acronis Cyber Foundation Program’s milestone five-year anniversary, check out our latest blog herehttps://www.acronis.com/en-us/blog/posts/acronis-cyber-foundation-program-celebrating-five-years-of-achievement/

About Acronis
Acronis unifies data protection and cybersecurity to deliver integrated, automated cyber protection that solves the safety, accessibility, privacy, authenticity, and security (SAPAS) challenges of the modern digital world. With flexible deployment models that fit the demands of service providers and IT professionals, Acronis provides superior cyber protection for data, applications, and systems with innovative next-generation antivirus, backup, disaster recovery, and endpoint protection management solutions powered by AI. With advanced anti-malware powered by cutting-edge machine intelligence and blockchain based data authentication technologies, Acronis protects any environment – from cloud to hybrid to on premises – at a low and predictable cost.

Acronis is a Swiss company, founded in Singapore. Celebrating two decades of innovation, Acronis has more than 2,000 employees in 45 locations. Acronis Cyber Protect solution is available in 26 languages in over 150 countries and is used by 16,000 service providers to protect over 750,000 businesses.

Press Contacts:
Julia Carfagno

Contact for press release:
Karl Bateson

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3adb134d-008a-4fa3-9be4-3b8f2e26e965

GlobeNewswire Distribution ID 8733883

Vista announces record full year performance 2022 with revenue up over 50% YOY

Thomas Flohr

Vista Founder & Chairman

  • Strong membership growth of subscription services around the world through market-leading VistaJet and XO brands, especially across Program membership with gross annual hours sold up 74% YOY and showing a run-rate at over 3x pre-COVID levels;
  • Significant continued investment in global infrastructure, scale and technology through landmark acquisitions of Air Hamburg, Jet Edge and Camber Technologies in 2022;
  • Additional 117 aircraft added to the Vista Members’ fleet in 2022, expanding to over 360 aircraft globally;
  • Strong momentum at the start of 2023 expected to continue across dynamic markets;
  • Investment in Dufour Aerospace to further support development of sustainable aviation technologies.

Dubai, January 23, 2022: Vista Global Holding (Vista), the world’s leading global private aviation group, provides a market update and overview into its exceptional performance for 2022, reflecting the positive trends across its dynamic global markets and unprecedented levels of demand from existing and new Members.

2022 was yet another outstanding year for Vista. The Group continues to see strong growth across its subscription solutions and services, with revenue up over 50% against the same period 2021. This has been driven by a surge of 74% in VistaJet’s Program membership gross hours sold during 2022, equating to over three times pre-pandemic levels, and gives great visibility on forward demand owing to three-year client signings.

The strong performance reflects yet another year of record-breaking flying across all core markets despite a series of macroeconomic events as the total growth in fight numbers increased globally by 28% YOY. Regionally, the U.S saw a 41% increase in number of flights during 2022, with Asia, Europe and the Middle East up 69%, 29% and 22% respectively. New York became the number one location for number of flights during the year, followed by London and Paris.

Thomas Flohr, Vista’s Founder and Chairman said: “It has been an incredible 2022 for Vista with strong growth across all of our core regions and offerings during the year. Our 2022 results clearly show that Vista is the go-to solution for new and existing Members who are increasingly turning to asset-free offerings. We have hugely invested in our global infrastructure, ensuring our clients have the best aircraft available, across every corner of the world, backed by the latest technology.

Our strong performance is supported by a significant expansion of our fleet in 2022 to support our commitment of providing the best value to our clients. The landmark acquisitions of both Air Hamburg — the largest private jet operator in Europe by number of flights — and Jet Edge the leading U.S. provider of large cabin and super-midsize charter and management services — significantly expanded our scale in the U.S., Europe and the Middle East, further cementing our leading global position. We also expanded our industry-leading Global 7500 fleet to 18. While our acquisition of Camber Technologies augments the Group’s existing technology capabilities to help further automate fleet scheduling, booking and sourcing.

As we start 2023, I am happy to announce Vista’s investment in Dufour Aerospace, supporting the development of sustainable aviation technologies and air mobility solutions with their innovative tilt-wing VTOL and eVTOL technologies and aerospace products, and reiterates our commitment to ensuring a greener future for our industry and clients.

I am incredibly excited for the future. More and more clients globally are recognizing that Vista provides the best value and end-to-end experience, and our expanded team of over 4,000 experts are fully committed to developing the next-era of innovative and advanced flying solutions across the globe. This will only strengthen Vista’s unrivaled customer offering and our position as the world’s largest on demand provider.


Global 7500

The expansion of Vista’s global fleet has been critical in meeting the surge in demand. During 2022, Vista added 117 net aircraft, including even more Global 7500 jets, now at 18 — the world’s largest fleet of this game-changing aircraft —bringing the Vista Members’ fleet to over 360 aircraft around the world. To best service clients over the next decade, the Group continues its investment in an extensive refurbishment program across the fleet including the adoption of KU or KA band Wi-Fi on board all aircraft.

During 2022, Vista streamlined it global subscription offerings across both the VistaJet and XO brands, introducing the VistaJet VJ25 membership and XO Membership. The evolving portfolio of membership options ensures every private aviation client can find a simple, flexible and secure solution for their flying needs. The Group’s focus on integration to offer seamless global services is further underpinned with the roll-out of Vista Flight Support.

As a business Vista has renewed its commitment to cleaner aviation and is championing the industry to progressively address the sustainability challenges issues it is facing. It continues to advocate externally for the widespread adoption of Sustainable Aviation Fuel (SAF) in the industry, as demonstrated by its agreement with AEG Fuels to purchase SAF produced by OMV at Vienna International Airport.

Notes to Editors
Statements in this release are based solely upon information available as of the date of this release, are not a comprehensive statement of the Group’s financial results or positions as of or for the FY 2022, and have not been audited, reviewed, or compiled by an independent registered accounting firm. Thus, the financial information in this release is preliminary, unaudited and subject to revision upon completion of the Group’s closing and audit processes. The Group assumes no obligation to update any information contained herein, save for any information required to be disclosed by law.

About Vista
Vista Global Holding’s (Vista) subsidiaries provide worldwide business flight services. A global group headquartered at the DIFC in Dubai, Vista integrates a unique portfolio of companies offering asset-free services to cover all key aspects of business aviation: guaranteed and on demand global flight coverage; subscription and Membership solutions; and cutting-edge mobility technology. The Group’s mission is to lead the change to provide clients with the most advanced flying services at the very best value, anytime, anywhere around the world. Vista’s knowledge and understanding of all facets of the industry deliver the best end-to-end offering and technology to all business aviation clients, through its VistaJet and XO branded services and duly licensed carriers. Vista is not a direct air carrier and does not operate or charter flights.
More Vista information and news at www.vistaglobal.com


Vista Global Holding Limited (“Vista”) does not own or operate any aircraft. All flights are performed by FAA-licensed/DOT-registered EASA or U.S. certified Vista group direct air carriers and/or partner operators. Vista holds non-controlling minority stakes in XOJET Aviation, GMJ Air Shuttle, JetSelect, Wester Air Charter, Red Wing Aviation and Talon Air.


GlobeNewswire Distribution ID 1000778627

Clinigen divests Proleukin® to Iovance Biotherapeutics for £166.7 million

23 January 2023

Clinigen divests Proleukin® to Iovance Biotherapeutics for £166.7 million

The deal includes a £41.7 million milestone payment and double-digit Proleukin® global sales royalties

Clinigen Limited (‘Clinigen’) (‘the Company’), the global pharmaceutical services company, has entered into an agreement to divest Proleukin® (interleukin-2 (aldesleukin)), to Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (‘Iovance’), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies (tumor infiltrating lymphocyte (TIL) and peripheral-blood lymphocyte (PBL)).

Terms of the agreement include an upfront payment of £166.7 million, a £41.7 million milestone payment upon first approval of lifileucel in advanced melanoma, and double-digit Proleukin® global sales royalties from Iovance to Clinigen. The transaction is expected to close in the first quarter of 2023, subject to required regulatory approvals and clearances and other customary closing conditions.

The divestment of Proleukin is an important step in Clinigen’s previously stated strategy of increasing its focus on those areas of the pharmaceutical services market where it has a growing and sustainable competitive advantage. Clinigen provides a strong and highly differentiated offering in pharmaceutical services where the platform provides market-leading access solutions from the clinical phase through to the commercial stage of the drug product life cycle.

David Bryant, Interim Chief Executive Officer of Clinigen, said: “Today’s announcement is a significant milestone for Clinigen as it continues its evolution as a business focused on critical high-value pharmaceutical services. The divestment helps accelerate that services focus, while returning value to the business and allowing Clinigen to benefit from potential future economic value in Proleukin.

“We have had a long-standing partnership with Iovance and believe they are the right partner to take Proleukin forward and ensure continued availability of this important medicine to patients and healthcare professionals.”

Greenhill & Co is serving as financial advisor and White & Case LLP as legal advisor to Clinigen.

Contact details

Clinigen Limited +44 (0)7957 984570
Michelle Shearly, Director of Communications michelle.shearly@clinigengroup.com
Consilium Strategic Communications

Mary-Jane Elliott / Matthew Cole / Jessica Hodgson

Tel: +44 (0) 20 3709 5700 Clinigen@consilium-comms.com

Notes to Editors

About Clinigen

Clinigen is a global, specialist pharmaceutical services company focused on providing ethical access to medicines. Its mission is to deliver the right medicine to the right patient at the right time. The Group supports pharmaceutical and biotech companies across the medical product lifecycle, from clinical through to commercial and operates from sites in North America, Europe, Africa and the Asia Pacific. Clinigen has more than 1,000 employees across five continents in 15 countries, and provides access in more than 120 countries every year.

For more information on Clinigen, please visit http://www.clinigengroup.com

About Proleukin

Proleukin (Aldesleukin is a recombinant interleukin-2 (IL-2), a cytokine whose role in the immune system has been extensively studied. At conventional doses it is used in the treatment of kidney cancer that has spread to another part of the body (metastatic kidney cancer). It is also currently being studied as part of adoptive cellular therapy. At significantly lower doses than those used in oncology aldesleukin has demonstrated immunomodulatory effects in certain auto-immune and inflammatory disease states by boosting the levels of a particular subset of white blood cells called T-regulatory lymphocytes (Tregs).

The Following Information is Intended for the U.S. Audience Only.

Proleukin® (aldesleukin) is indicated for the treatment of adults with metastatic renal cell carcinoma (mRCC) and metastatic melanoma (mM).

Summary of Important Safety Information for Proleukin® (aldesleukin) for injection, for intravenous infusion.


Therapy with Proleukin® (aldesleukin) should be restricted to patients with normal cardiac and pulmonary functions as defined by thallium stress testing and formal pulmonary function testing. Extreme caution should be used in patients with a normal thallium stress test and a normal pulmonary function test who have a history of cardiac or pulmonary disease.

Proleukin should be administered in a hospital setting under the supervision of a qualified physician experienced in the use of anticancer agents. An intensive care facility and specialists skilled in cardiopulmonary or intensive care medicine must be available.

Proleukin administration has been associated with capillary leak syndrome (CLS) which is characterized by a loss of vascular tone and extravasation of plasma proteins and fluid into the extravascular space. CLS results in hypotension and reduced organ perfusion which may be severe and can result in death. CLS may be associated with cardiac arrhythmias (supraventricular and ventricular), angina, myocardial infarction, respiratory insufficiency requiring intubation, gastrointestinal bleeding or infarction, renal insufficiency, edema, and mental status changes.

Proleukin treatment is associated with impaired neutrophil function (reduced chemotaxis) and with an increased risk of disseminated infection, including sepsis and bacterial endocarditis. Consequently, preexisting bacterial infections should be adequately treated prior to initiation of Proleukin therapy. Patients with indwelling central lines are particularly at risk for infection with gram positive microorganisms. Antibiotic prophylaxis with oxacillin, nafcillin, ciprofloxacin, or vancomycin has been associated with a reduced incidence of staphylococcal infections.

Proleukin administration should be withheld in patients developing moderate to severe lethargy or somnolence; continued administration may result in coma.


Proleukin® (aldesleukin) is indicated for the treatment of adults with metastatic renal cell carcinoma (metastatic RCC).

Proleukin is indicated for the treatment of adults with metastatic melanoma.

Careful patient selection is mandatory prior to the administration of Proleukin.

Evaluation of clinical studies to date reveals that patients with more favorable ECOG performance status (ECOG PS 0) at treatment initiation respond better to Proleukin, with a higher response rate and lower toxicity. Therefore, selection of patients for treatment should include assessment of performance status.

Experience in patients with ECOG PS > 1 is extremely limited.


Proleukin® (aldesleukin) is contraindicated in patients with a known history of hypersensitivity to interleukin-2 or any component of the Proleukin formulation.

Proleukin is contraindicated in patients with an abnormal thallium stress test or abnormal pulmonary function tests and those with organ allografts. Retreatment with Proleukin is contraindicated in patients who have experienced the following drug-related toxicities while receiving an earlier course of therapy: sustained ventricular tachycardia (≥ 5 beats), cardiac arrhythmias not controlled or unresponsive to management, chest pain with ECG changes, consistent with angina or myocardial infarction, cardiac tamponade, intubation for > 72 hours, renal failure requiring dialysis > 72 hours, coma or toxic psychosis lasting > 48 hours, repetitive or difficult to control seizures, bowel ischemia/perforation, GI bleeding requiring surgery.


Because of the severe adverse events which generally accompany Proleukin therapy at the recommended dosages, a thorough clinical evaluation should be performed to identify patients with significant heart, lung, kidney, liver or central nervous system impairment in whom Proleukin is not indicated for use. Patients with normal heart, lung, liver and central nervous system function may experience serious, life-threatening or fatal adverse events.

Should adverse events, requiring dose modification occur, dosage should be withheld rather than reduced.

Proleukin has been associated with exacerbation of preexisting autoimmune disease and inflammatory disorders. In some cases, the onset of new autoimmune diseases, such as vitiligo, may occur. Symptomatic hyperglycemia and/or diabetes mellitus have been reported during Proleukin therapy.

All patients should have thorough evaluation and treatment of CNS metastases and have a negative scan prior to receiving Proleukin therapy. New neurologic signs, symptoms, and anatomic lesions following Proleukin therapy have been reported in patients without evidence of CNS metastases. Neurologic signs and symptoms associated with Proleukin therapy usually improve after discontinuation of Proleukin therapy; however, there are reports of permanent neurologic defects. In patients with known seizure disorders, extreme caution should be exercised as Proleukin may cause seizures.


Patients should have normal cardiac, pulmonary, hepatic, and CNS function at the start of therapy. Capillary leak syndrome (CLS) begins immediately after Proleukin® (aldesleukin) treatment starts and is marked by increased capillary permeability to protein and fluids and reduced vascular tone.

Proleukin® (aldesleukin) treatment should be withheld for failure to maintain organ perfusion as demonstrated by altered mental status, reduced urine output, a fall in the systolic blood pressure below 90 mm Hg or onset of cardiac arrhythmias.

Recovery from CLS begins soon after cessation of Proleukin therapy. Usually, within a few hours, the blood pressure rises, organ perfusion is restored and reabsorption of extravasated fluid and protein begins.

Kidney and liver function are impaired during Proleukin treatment. Use of concomitant nephrotoxic or hepatotoxic medications may further increase toxicity to the kidney or liver.

Mental status changes including irritability, confusion, or depression which occur while receiving Proleukin may be due to bacteremia or early bacterial sepsis, hypoperfusion, occult CNS malignancy, or direct Proleukin-induced CNS toxicity. Patients should be evaluated for these and other causes of mental status changes. Alterations in mental status due solely to Proleukin therapy may progress for several days before recovery begins. Rarely, patients have sustained permanent neurologic deficits.

Proleukin enhancement of cellular immune function may increase the risk of allograft rejection in transplant patients.

Serious manifestations of eosinophilia involving eosinophilic infiltration of cardiac and pulmonary tissues can occur following Proleukin.


The rate of drug-related deaths in the 255 metastatic RCC patients who received single-agent Proleukin® (aldesleukin) was 4% (11/255); the rate of drug-related deaths in the 270 metastatic melanoma patients who received single-agent Proleukin was 2% (6/270).

Adverse events are frequent, often serious, and sometimes fatal. The following adverse events (Grades 1-4) were seen in ≥ 30% of 525 patients (255 with metastatic kidney cancer and 270 with metastatic melanoma) treated with Proleukin: low blood pressure (71%), diarrhea (67%), low urine output (63%), chills (52%), vomiting (50%), shortness of breath (43%), rash (42%), increased bilirubin in blood (40%), decreased clotting of blood (37%), nausea (35%), confusion (34%), and decreased kidney function (33%).

Please see the full Prescribing Information, including Boxed Warning, for Proleukin® (aldesleukin) for injection, for intravenous infusion.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

GlobeNewswire Distribution ID 1000778628

Topps Tiles Transforms Fleet Delivery Operations and Strategic Modelling with Descartes’ Route Optimisation Solution

LONDON and ATLANTA, Jan. 23, 2023 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Topps Tiles, the leading U.K. tile retailer, is optimising its fleet delivery capabilities with Descartes’ cloud-based route planning and optimisation solution. By working with Descartes, Topps Tiles is decreasing the average kilometers driven per delivery route by two percent and gaining a better understanding of the potential impact of changes to its delivery strategies.

“With over 300 stores nationwide in the U.K., we’re continuously evaluating how to maintain a high degree of customer service while reducing operational costs, especially today’s high transportation costs,” said Simon Macdonald, National Transport Manager, Topps Tiles. “Working with Descartes, we’ve replaced manual, spreadsheet-based processes with automated route planning to optimise the volume of tiles being delivered at any given time, as well as the routes our vehicles are travelling. Descartes’ strategic route modelling capabilities are also enabling us to model delivery scenarios and make more informed strategic decisions, which would have been nearly impossible with traditional resource-intensive analytical methods.”

Part of its Routing, Mobile and Telematics suite, Descartes’ route planning and optimisation solution helps brands, retailers and logistics providers reduce costs with more agile and efficient routing, improve fleet resource management by generating additional delivery capacity and become more sustainable through the reduction of their CO2 footprint and their use of paper across the route network. The strategic route modelling capabilities allow companies to understand and optimize their delivery and customer service strategies before having to execute them. Descartes’ mobile application helps drivers perform their daily routes, keeps managers aware of the progress and provides an accurate estimated-time-of-arrival (ETA) to notify customers of their deliveries. Proof of delivery (POD) capabilities support customer service excellence and order accuracy through real-time mobile communication.

“Topps Tiles’ long-term success is based upon its ability to continually provide customers with a superior shopping experience while offering cost competitive pricing,” said Pól Sweeney, VP Fleet Sales in Europe at Descartes. “We’re delighted to help Topps Tiles minimize its operational costs today through our route planning and optimisation solution and in the future with our strategic route modelling capabilities.”

About Topps Tiles Plc

Topps Tiles Plc is the UK’s largest specialist supplier of tiles and associated products, targeting the UK domestic refurbishment and commercial markets and serving homeowners, trade customers, architects, designers and contractors from 304 nationwide Topps Tiles stores, four commercial showrooms and six websites: www.toppstiles.co.ukwww.parkside.co.ukwww.protilertools.co.ukwww.northantstools.co.ukwww.premiumtiletrim.co.uk and www.tilewarehouse.co.uk. Since opening its first store in 1963, Topps has maintained a simple operating philosophy ‐ inspiring customers with unrivalled product choice and providing exceptional levels of customer service.  For further information on the Group, please visit http://www.toppstilesplc.com/.

About Descartes

Descartes (Nasdaq:DSGX) (TSX:DSG) is the global leader in providing on-demand, software-as-a-service solutions focused on improving the productivity, performance and security of logistics-intensive businesses. Customers use our modular, software-as-a-service solutions to route, schedule, track and measure delivery resources; plan, allocate and execute shipments; rate, audit and pay transportation invoices; access global trade data; file customs and security documents for imports and exports; and complete numerous other logistics processes by participating in the world’s largest, collaborative multimodal logistics community. Our headquarters are in Waterloo, Ontario, Canada and we have offices and partners around the world. Learn more at www.descartes.com, and connect with us on LinkedIn and Twitter.

Global Media Contact
Andrew Tavener                                                     
Tel: +44 (0)7833 444047                        

Cautionary Statement Regarding Forward-Looking Statements

This release contains forward-looking information within the meaning of applicable securities laws (“forward-looking statements”) that relate to Descartes’ solution offering and potential benefits derived therefrom including potential increases in delivery volumes and increases in on-time deliveries and other matters. Such forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements to differ materially from the anticipated results, performance or achievements or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the factors and assumptions discussed in the section entitled “Certain Factors That May Affect Future Results” in documents filed with the Securities and Exchange Commission, the Ontario Securities Commission and other securities commissions across Canada including Descartes’ most recently filed management’s discussion and analysis. If any such risks actually occur, they could materially adversely affect our business, financial condition or results of operations. In that case, the trading price of our common shares could decline, perhaps materially. Readers are cautioned not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Forward-looking statements are provided for the purposes of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes. We do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

GlobeNewswire Distribution ID 8733601

Tobias Menne is Appointed to the Advisory Board of crop.zone

Tobias Menne is appointed to the advisory board of crop.zone

Tobias Menne is appointed to the advisory board of crop.zone

AACHEN, Germany, Jan. 23, 2023 (GLOBE NEWSWIRE) — crop.zone, the specialist for herbicide-free siccation, continues to focus on new partnerships and cooperations. With Tobias Menne as a new member of the advisory board, the company has now gained an important expert in this field. In the long term, the crop.zone strategy is to be expanded and further improved by the competencies and the comprehensive network of the 46-year-old.

Tobias Menne recently set up the SmartFarming joint venture between BASF and BOSCH and led it on the supervisory board. He now contributes this expertise to the crop.zone supervisory board in establishing new partnerships. This is an essential lever in managing the company and shaping a strategy to successfully bring crop.zone’s hybrid herbicide technology to market. The board works closely with the leadership team to capitalize on future growth opportunities.

“Without system breakers in weed management, farmers will not be able to grow sustainably. Digitalisation and sustainability are indispensable nowadays.” – Menne

In order to make the transition to a new technology accessible to farmers, new business models will emerge between farmers, agricultural machinery manufacturers and technology providers such as crop.zone. As an expert in digital solutions in agriculture, Tobias Menne brings his experience in creating outcome-oriented business models between agricultural retailers and crop protection manufacturers to the table here. “Without system breakers in weed management, farmers will not be able to grow sustainably. Digitalisation and sustainability are indispensable nowadays,” explains Tobias Menne. Dirk Vandenhirtz, CEO of crop.zone, is looking forward to the support of Tobias Menne: “New partnerships are of high relevance to establish new innovative solutions and ultimately to advance the agricultural machinery industry and make it fit for the future.”

Tobias Menne started his professional career in 2003 at Bayer as Managing Director for Bulgaria and Managing Director for Ukraine. He then worked in various management positions at Mriya Agro Holding (Switzerland), Bayer, BASF, xarvio® Digital Farming Solutions. Since January 2023, he is Chief Commercial Officer at constellr, a manufacturer of aerospace components.

Tobias Menne studied Digitalisation & Future of Industry at Singularity University in San Francisco and Strategy and Agricultural Economics at Harvard Business School. He completed his Master of Business Administration (MBA) at the University of Bradford with a focus on marketing and finance.

Contact Information:
Dirk Vandenhirtz
CEO – crop.zone
+1 (919) 251-6320 / +49 2408 598

Related Files

crop.zone Pressemitteilung Tobias Menne EN.pdf

crop.zone Pressemitteilung Tobias Menne DE.pdf

Related Images

Image 1: Tobias Menne is appointed to the advisory board of crop.zone

crop.zone, the specialist for herbicide-free siccation, continues to focus on new partnerships and cooperations.

This content was issued through the press release distribution service at Newswire.com.


GlobeNewswire Distribution ID 8733976